🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the trial is to evaluate a patient's response to a Fibroblas...
Status
Terminated
Location
Mayo Clinic - AZ
Start Date
2020-01-28
Trial ID
NCT04024436
Treatments Being Tested
The global objective of this Basket of Basket study is to evaluate the anti...
Status
Recruiting
Location
Institut Gustave Roussy
Start Date
2018-12-10
Trial ID
NCT03767075
Treatments Being Tested
This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 stud...
Status
Active Not Recruiting
Location
University of California Los Angeles UCLA - Cancer Care - Santa Monica
Start Date
2023-07-13
Trial ID
NCT05945823
Treatments Being Tested
BBI-355 is an oral, potent, selective checkpoint kinase 1 (or CHK1) small m...
Status
Terminated
Location
UCLA Medical Center
Start Date
2023-03-24
Trial ID
NCT05827614
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
The FUTURE trial is a prospective, multicentre, exploratory, open-label pha...
Status
Recruiting
Location
Klinikum St. Marien Amberg
Start Date
2025-12-16
Trial ID
NCT06722183
Treatments Being Tested
This is a phase 1, non-randomized open-label, multicenter platform study de...
Status
Recruiting
Location
A site selected by Taiho Pharmaceutical Co., Ltd.
Start Date
2021-06-01
Trial ID
NCT04999761
This is an open-label, multinational, parallel 2-arm, randomized Phase 3 st...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2021-01-06
Trial ID
NCT04093362
Treatments Being Tested
MULTISARC is a randomized multicenter study assessing whether high throughp...
Status
Completed
Location
Institut Bergonie
Start Date
2019-10-19
Trial ID
NCT03784014
To compare overall survival (OS) of patients in Futibatinib and Zimberelima...
Status
Recruiting
Location
Research Site
Start Date
2026-06-24
Trial ID
NCT07710885
Treatments Being Tested